Trump says Exxon and Chevron made 'too much money' off high oil prices during Iran conflict: 'I don't like it'
Trump says Exxon and Chevron made 'too much money' off high oil prices during Iran conflict: 'I don't like it'
Market narrative
Move between stock news, official company releases, crypto, and FX without losing the path back to ticker research.
Trump says Exxon and Chevron made 'too much money' off high oil prices during Iran conflict: 'I don't like it'
Stocks
Accelerant Holdings (ARX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Longbridge boosted EFC's Q1 results with strong reverse mortgage growth, but rising funding costs and one-time gains cloud the path to sustained earnings.
Hopes are running high that high-profile software provider Palantir can shake off its nine-month bear market and rally after earnings.
Boeing and Airbus are both showing notable improvements in aircraft deliveries, with Airbus leading in both orders and delivery volumes. Airbus secured 821 net orders versus Boeing's 408 in the first half of 2026, translating into a $12.6 billion order value lead for Airbus. Combined deliveries have nearly recovered to pre-crisis levels, with Airbus already in growth mode and Boeing still in recovery, trailing by roughly three years.
The stock's yield is more than six times the S&P 500 average.
SGI is expected to post Q2 earnings and revenue growth as premium products, direct sales and productivity efforts help offset demand and cost pressures.
The second-quarter 2026 reporting cycle of the Medical sector is currently in full swing. The sector mainly comprises pharma/biotech and medical device companies.
Wall Street's mood on Joby Aviation (NYSE:JOBY | JOBY Price Prediction) has shifted from skepticism to cautious optimism.
/PRNewswire/ -- Made4net, a global provider of warehouse management systems (WMS) and end-to-end supply chain execution software, proudly congratulates nine
Both had similar issues, but one is much easier to justify because of its business direction.
Baltimore, MD, Aug. 03, 2026 (GLOBE NEWSWIRE) -- The AI boom looks like it's being driven by overwhelming customer demand. Jim Rickards says a good deal of that demand may be manufactured, by the AI companies themselves. In a new presentation, the former advisor to the CIA and the Pentagon explains a money-go-round he believes sits at the center of the boom, and why it echoes the exact scheme that inflated telecom stocks before the dotcom crash.
/PRNewswire/ -- Morse and Main, a Winter Park-based strategic branding and advertising agency, has been named a Best Advertising Agency in Orlando magazine's
Apple is making a big bet that customers would rather pay by the month than all at once, with its new Apple Upgrade program designed to make upgrading your devices feel more like a subscription. Bloomberg's Mark Gurman joins Ed Ludlow on "Bloomberg Tech.
Shares of SoFi Technologies (NASDAQ:SOFI | SOFI Price Prediction) are up 9% to $17.82 in Monday afternoon trading, riding a broad fintech and market rally.
Micron Technology, Inc. is upgraded to Buy after a significant selloff, with fundamentals strengthening and valuation now highly attractive. MU's guided free cash flow and capex plan suggest the potential to retire 8–19% of its float via buybacks over two years. Even under conservative assumptions, MU trades at a mid-teens forward P/E on FY28 earnings, pricing in a worst-case scenario.
Investors need to pay close attention to CUBI stock based on the movements in the options market lately.
MSTR is prioritizing STRC's return to par, stronger cash coverage and flexible Bitcoin sales after a weak second quarter.
/PRNewswire/ -- Marquis Who's Who honors Slobodan S. Bekvalac for his leadership in adaptive architecture. Mr. Bekvalac is recognized as an industry leader and
/PRNewswire/ -- The Supervisory Board of Fresenius Medical Care AG, the world's leading provider of products and services for individuals with renal disease,